Cargando…
The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma.
A recently developed enzyme assay, utilizing [125I]-iododeoxyuridine as substrate, and capable of detecting normal levels of serum deoxythymidine kinase (s-dTk), was used in an investigation of sera from 155 untreated patients with non-Hodgkin's lymphoma (NHL). The patients were classified at t...
Autores principales: | Gronowitz, J. S., Hagberg, H., Källander, C. F., Simonsson, B. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1983
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011337/ https://www.ncbi.nlm.nih.gov/pubmed/6849793 |
Ejemplares similares
-
Deoxythymidine kinase in the tumour cells and serum of patients with non-Hodgkin lymphomas.
por: Rehn, S., et al.
Publicado: (1995) -
Serum thymidine kinase in acute leukaemia.
por: Hagberg, H., et al.
Publicado: (1984) -
Lymphocyte markers in non-Hodgkin's lymphomas.
por: Payne, S. V., et al.
Publicado: (1977) -
The Outcome of Hodgkin Lymphoma With Reference to Prognostic Markers
por: Ahmed, Rehana, et al.
Publicado: (2022) -
FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas
por: Barrington, Sally F., et al.
Publicado: (2017)